The phrase CJC-1295 without DAC can conceal an important naming question. A study of a DAC-containing analogue cannot automatically supply evidence for a material sold without that modification. Sermorelin is another distinct name that requires its own identity record.
Ipamorelin discussions commonly involve the ghrelin receptor. Selectivity, however, is an experimental property rather than a promise established by the product name. The IUPHAR receptor resource provides terminology and links to pharmacological literature.
5-Amino-1MQ is discussed in NNMT-inhibitor research as a small molecule, not as a peptide ligand. Placement in a peptide store does not change that chemical distinction. The cited research is preclinical and does not establish human-use suitability.
A fragment designation is incomplete without the parent sequence, residue numbering and any modifications. The AOD-9604 label should be checked against a complete molecular identity before findings about a growth-hormone fragment are applied to a catalog material.
Researcher access
Products are intended solely for laboratory research, not for human or veterinary use. This acknowledgement is not identity verification.